Re: When EMA and FDA decisions conflict: differences in patients or in regulation?
The ostensible differences between the EMA (Europe) and the FDA (US) are superficial and trivial. In reality, these “differences” are a distinction without a difference, because both regulatory agencies have a consistently cozy relationship with Big Pharma, as evinced by the priciness of pharmaceuticals, the prevalence of polypharmacy, and a lucrative revolving door. To quote the Roman satirist Juvenal, “Who will protect us from our protecters?”
Competing interests: No competing interests